Navigation Links
Goat Anti-Mouse IgG (H & L) Antibody, Gold Conjugated, 50 OD

ProductsGoat Anti-Mouse IgG (H & L) Antibody, Gold Conjugated, 50 OD
Company BioAssay Works, L.L.C.
Item Goat Anti-Mouse IgG (H & L) Antibody, Gold Conjugated, 50 OD
Features 
Description Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD
Info BioAssay Works, L.L.C.
Customer Service: 301-874-8888
Web site: http://www.bioassayworks.com

Related medicine products :

1. Human Anti-Mouse Antibody (HAMA), ELISA
2. Goat Anti-Mouse IgG Antibody, Gold Conjugated
3. Adenovirus Antibody, IgG
4. Adenovirus Antibody, IgM
5. Anti-Cardiolipin Antibody, IgG
6. Anti-Cardiolipin Antibody, IgM
7. Anti-Centromere Antibody, IgG
8. Anti-dsDNA Antibody, IgG
9. Anti-GBM Antibody, IgA (IFA)
10. Anti-GBM Antibody, IgG (IFA)
11. Anti-GBM Antibody, IgG (ELISA)
...ly invasive surgery is founded on superior medical...-Chip cameras, 1-Chip cameras, Light sources, Coup...nding needs., ,Superior resolution and color repr...meras, and are the benchmark by which all other me...
...ra System provides easy-to-use features, auto iris...amera head construction is based on Solos durable ...era System, International (GS9900-PAL) includes: ,...rd and video cables , (GS 9905) Camera head with 3...
Provides a combination of concentrated cold / hot and compression for the elbow
Provides extended cold therapy for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and speed recovery.
Medicine Products:
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...The US-based pharmaceutical multi-national, the Ab...uvia in low and low-middle income countries to one...d Health Organization’s Director-General Margaret ...atment of HIV-1 infected adults and children above...
...An analysis of a previously published research in ... has revealed that foods rich in cocoa are benefic...which may not actually help. Current guidelines a...h blood pressure) to eat more fruits and vegetable...
...Deirdre Barlow is obviously stressed. Who wouldn’t...d enough reason to show her puffing her way throug... week? Deirdre Anne Barlow (née Hunt, formerly La...aracter on the ITV soap opera Coronation Street. S...
...Two health groups are joining forces to fund three...Foundation and the American Cancer Society// are c...ity Foundation and American Cancer Society Lung Ca... to three researchers whose novel approaches may h...
Other Medicine News:Health News:Abbott to Subsidize Price of HIV Drug 2Health News:Blood Pressure Tackled Better With Cocoa Than Tea 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 3Health News:Groups Join Forces to Fund Promising Lung Cancer Research 2
(Date:10/8/2008)...nolimumab Program to be Discontinued and Headcount...lts of its Portfolio Review; Zanolimumab Program ... Number of Employees... Genmab A/S (OMX: GEN),announced today that it is ...4(R)). In addition, as a result of a portfolio rev...
(Date:10/8/2008)...inical program to evaluate TAXUS(R) Element(TM) Pl...ent, NATICK, Mass., Oct. 8 /PRNewswire-FirstCall/...day announced that it has completed enrollment in,...y,s third-generation,TAXUS(R) Element(TM) paclitax...ogram has enrolled nearly 1,500 patients at 100 U....
(Date:10/8/2008)...France, Oct. 8 /- Vical Incorporated ...ical data and new nonclinical data,demonstrating t...adly,applicable in DNA- and protein-based infectio...nes. Alain P. Rolland, Pharm.D., Ph.D., Vical,s,Se...resent the data today,Wednesday, October 8, at th...
(Date:10/7/2008)...EGO, Oct. 7 /- Prometheus Laboratorie...announced findings from its,development of PROMETH...st,for irritable bowel syndrome (IBS). The finding... of particular biomarkers in blood samples,between...hese biomarkers,combined with a proprietary algor...
Breaking Medicine Technology:Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Exclusion of common bile duct stones prior to gallstone operations 5081 1Exclusion of common bile duct stones prior to gallstone operations 5081 2UCLA Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine 5078 1UCLA Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine 5078 2Gamma interferon could aid fight against fungal infections 1046 1Gamma interferon could aid fight against fungal infections 1046 2Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 5074 1Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 5074 2Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 5074 3Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 5074 4Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 5074 5
...One Month Study in Seventy Type 2 Diabetes Patient...hnologies Inc.,(TSX:CJB) today announced positiv...le-dose clinical study for the treatment of Type 2...(TM):Exendin-4.,Results from the study demonstra... tolerated and, when administered once-weekly at e...
...VERLY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inot... presentation of,positive Phase 2 clinical data de...potential for INO-1001 as a preventative agent for...ed in subjects,with acute ST-elevated myocardial i...coronary intervention. The presentation was,made i...
Other Medicine Technology:PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 2PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 3PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 4Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4